FLEXION THERAPEUTICS INC - NOTE 3.375% 5/0

CUSIP: 33938JAB2

Q3 2018 13F Holders as of 30 Sep 2018

Type / Class
Debt / NOTE 3.375% 5/0
Market price (% of par)
101.0%
Total 13F principal
$180,626,000
Principal change
-$3,228,000
Total reported market value
$183,142,000
Number of holders
21
Value change
-$5,111,367
Number of buys
13
Number of sells
7

Quarterly Holders Quick Answers

What is CUSIP 33938JAB2?
CUSIP 33938JAB2 identifies 33938JAB2 - FLEXION THERAPEUTICS INC - NOTE 3.375% 5/0 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of FLEXION THERAPEUTICS INC - NOTE 3.375% 5/0 as of Q3 2018

As of 30 Sep 2018, FLEXION THERAPEUTICS INC - NOTE 3.375% 5/0 was held by 21 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $180,626,000 in principal (par value) of the bond. The largest 10 bondholders included WELLS FARGO & COMPANY/MN, Allianz Asset Management GmbH, ZAZOVE ASSOCIATES LLC, SILVERBACK ASSET MANAGEMENT LLC, Linden Advisors LP, CALAMOS ADVISORS LLC, ADVENT CAPITAL MANAGEMENT /DE/, FMR LLC, CAPSTONE INVESTMENT ADVISORS, LLC, and WELLINGTON MANAGEMENT GROUP LLP. This page lists 21 institutional bondholders reporting positions for the Q3 2018 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.